TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Biopharma AS
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
16,119
|
18,824
|
19,483 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
2,486
|
617
|
2,745 |
| Total assets |
7,458
|
11,510
|
11,295 |
| Current assets |
7,458
|
11,510
|
11,295 |
| Current liabilities |
3,031
|
8,667
|
8,945 |
| Equity capital |
3,701
|
1,878
|
1,076 |
| - share capital |
20
|
21
|
22 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
49.6%
|
16.3%
|
9.5% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
15.4%
|
3.3%
|
14.1% |
| Return on assets (ROA) |
33.3%
|
5.4%
|
24.3% |
| Current ratio |
246.1%
|
132.8%
|
126.3% |
| Return on equity (ROE) |
67.2%
|
32.9%
|
255.1% |
| Change turnover |
-1,548
|
364
|
-3,965 |
| Change turnover % |
-9%
|
2%
|
-17% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.